Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice
- 31 August 2007
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 17 (8) , 639-650
- https://doi.org/10.1016/j.nmd.2007.04.008
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophyAnnals of Neurology, 2005
- Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophyBiochemical Journal, 2004
- Effect of creatine supplementation on skeletal muscle of mdx miceMuscle & Nerve, 2004
- Correction of the Dystrophic Phenotype byIn VivoTargeting of Muscle Progenitor CellsHuman Gene Therapy, 2003
- Reduced density of intramembranous particle clusters: freeze-fracture study of mdx mouse muscle plasma membraneMedical Molecular Morphology, 2003
- Studies of the dynamics of skeletal muscle regeneration: the mouse came back!Biochemistry and Cell Biology, 1998
- Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgeneNature, 1996
- Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal musclesCellular and Molecular Life Sciences, 1994
- Small‐caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophyMuscle & Nerve, 1988
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987